Author | Agnes Shanley

UBM Americas

Agnes Shanley is senior editor of BioPharm International.

Articles

Lower Taxes, More Flexibility Crucial to Retaining Pharma Employment

February 11, 2020

Article

As politicians focus on drug cost reduction, biopharmaceutical companies in the US are moving to states with lower taxes, and relocating some facilities that had been offshore.

Managing Risk for Cell and Gene Therapy Logistics

February 05, 2020

BioPharm International

Article

Vein-to-vein programs are focusing on data access and traceability.

Drug Prices: Revisiting the Social Contract

January 20, 2020

BioPharm International

Article

While the US public and law makers push for price controls, pharma’s venture capitalists have other ideas for balancing innovation and affordability.

Getting to the Root of Quality Problems

January 01, 2020

BioPharm International

Article

Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.